| CPC C12M 23/16 (2013.01) [C12M 23/38 (2013.01); C12M 25/06 (2013.01); C12M 29/04 (2013.01); C12N 5/0679 (2013.01)] | 2 Claims |
|
2. A method for fabricating an organ-on-a-chip, comprising:
forming each of a first layer having a first microfluidic channel to culture a first organ cell, the first microfluidic channel formed in a shape of a hole with a predetermined length, a second layer having a second microfluidic channel to measure a rate or amount of drug absorption into the first organ cell or a second organ cell, the second microfluidic channel formed in a shape of a hole with a predetermined length, and a third layer having a third microfluidic channel to culture the second organ cell, the third microfluidic channel formed in a shape of a hole with a predetermined length using polydimethylsiloxane (PDMS);
connecting the first layer, the second layer, and the third layer with a first membrane interposed between the first layer and the second layer and a second membrane interposed between the second layer and the third layer, wherein a cover substrate, which is made of polycarbonate, is connected with a base substrate at an upper surface of the first layer and a lower surface of the third layer; and
culturing a first organ cell in the first microfluidic channel using the first membrane as a substrate and a second organ cell in the third microfluidic channel using the second membrane as a substrate,
wherein the first membrane is a porous flexible membrane through which a material can move from the second microfluidic channel to the first microfluidic channel,
wherein the second membrane is a porous flexible membrane through which a material can move from the second microfluidic channel to the third microfluidic channel,
wherein a cover substrate, which is made of polycarbonate, is connected with a base substrate at an upper surface of the first layer and a lower surface of the third layer,
wherein the cover substrate includes a first inlet in communication with the first microfluidic channel to inject a predetermined drug or culture medium into an end of the first microfluidic channel,
wherein the cover substrate includes a second inlet in communication with the second microfluidic channel to inject a predetermined drug or culture medium into an end of the second microfluidic channel, and
wherein the cover substrate includes a third inlet in communication with the third microfluidic channel to inject a predetermined drug or culture medium into an end of the third microfluidic channel,
wherein a reaction chamber including a part of the first microfluidic channel, a part of the second microfluidic channel and a part of the third microfluidic channel is provided in at least one point or region on the second microfluidic channel at which the first microfluidic channel is positioned vertically above thereof and the third microfluidic channel is positioned vertically below thereof,
wherein, when the first microfluidic channel, the second microfluidic channel, and the third microfluidic channel are projected onto an imaginary plane parallel to the second layer, an angle between the first microfluidic channel and the second microfluidic channel and an angle between the second microfluidic channel and the third microfluidic channel are formed to be equal, and
wherein the reaction chamber tests the amount of absorption of the drug injected through the second microfluidic channel into the first organ cell or the second organ cell at the same time.
|